FST BLOG
We welcome blogs on issues across Science, Technology, Research and Innovation, and on the activities of the Foundation. To publish a blog on this site, please email Gavin Costigan (gavin.costigan@foundation.org.uk).
Note: The Foundation for Science and Technology is strictly neutral. Any views expressed in these blogs are those of the authors and not of the Foundation.
How do you fix a leaky pipeline? Improving conditions for Black researchers
- 5 December, 2022
- Education, General, Technology
- Dr Faith Uwadiae
Science and technology are suffering from a huge problem. One that it is starting to acknowledge but has not really comprehended the scale of the issue and the pace of change required to fix it. The UK government has a grand plan to strengthen the UK’s position as a global science and technology superpower, but for who? Dr Faith Uwadiae discusses science and technology for black researchers.
Read MoreWhy we must change perceptions of engineering: the case for National Engineering Day
- 2 November, 2022
- Education, Technology
- Jo Trigg
In 2022, 'National Engineering Day' is held on the 2nd November as a celebration for the impact of engineering and engineers. In this blog, Joe Trigg (Director of Communications and Engagement at the Royal Academy of Engineering) discusses the significance of day, the importance of engineering globally and the limitations faced by the field.
Read MoreCOP 27: A Preview
- 24 October, 2022
- Environment
- Alyssa Gilbert, Director of Policy & Translation, Grantham Institute for Climate Change, Imperial College
In this blog, Alyssa Gilbert, Director of Policy & Translation at the Grantham Institute, Imperial College, previews the COP27 climate change meeting, which is being held in Sharm El Sheikh in November 2022, and the possibility of progress in climate finance, adaptation and loss & damage.
Read MoreDelivering a UK Science and Technology Strategy
- 4 August, 2022
- Lord Holmes of Richmond MBE
On 4th August 2022, the House of Lords Science and Technology Committee published a report "Science and technology superpower": more than a slogan? In this blog, Lord Holmes of Richmond sets out some of the key findings and recommendations.
Read MoreA personal message to Science and Technology Future Leaders
- 20 November, 2021
- Dr Carlanne Stone
In this blog, Dr Carlanne Stone outlines the experience of taking part in the 2021 Foundation Future Leaders scheme - and encourages others to apply for next year.
Read MoreWill your energy bills go down with nuclear energy production?
- 29 October, 2021
- Chloe Davies
In this blog, Chloe Davies discusses the Nuclear Energy Regulated Asset Base model introduced by the Government, what this means for energy bills and for achieving Net Zero emissions.
Read MoreBuilding the Future Economy
- 18 October, 2021
- Indro Mukerjee
In this blog, Indro Mukerjee, Chief Executive of Innovate UK, gives a foretaste of Innovate UK's Plan for Action, soon to be published.
Read MorePutting patients at the heart of early-phase clinical trials
- 15 October, 2021
- Jules Payne, CEO of Heart UK – The Cholesterol Charity
In this blog, Jules Payne, CEO of Heart UK - The Cholesterol Charity, argues that patients need to be fully aware of what clinical trials are seeking to achieve, and the opportunities to participate in them. Patient groups can help in ensuring clinical trial information is written in a way accessible to those who will benefit from them - patients.
Read MoreImproving clinical trial success by optimising patient selection – how can UK healthcare data resources help?
- 28 September, 2021
- Daniel Swerdlow, Senior Medical Director at Silence Therapeutics UK
In this latest blog, Daniel Swerdlow, Senior Medical Director at Silence Therapeutics UK, discusses how healthcare data can be used to improve the success of clinical trials by optimising patient selection.
Read MoreA scientific superpower: harnessing the UK’s early-phase research capabilities
- 7 September, 2021
- Professor Sir Gordon Duff
Professor Sir Gordon Duff, former Chair of the MHRA and current head of the Science and Technology Advisory Board at Silence Therapeutics, discusses the need to boost early-phase clinical research and ensure the UK continues to be an attractive and competitive destination for companies to design, trial and develop novel medicines for common and rare diseases.
Read More